Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (61-70 of 260) with videos related to

Pageof 26
Sort By:
Cancer Treatment Reports|February 1, 1985
Intracavitary cisplatin chemotherapy for mesotheliomaC E Pfeifle, S B Howell, M Markman
Cancer Chemotherapy and Pharmacology|January 1, 1981
Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexateS B Howell, S J Mansfield, R Taetle
Anticancer Research|November 1, 1994
In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenograftsR Jamshidipour, E B Pinho, S B Howell
American Journal of Obstetrics and Gynecology|June 15, 1985
Intraperitoneal chemotherapy for advanced ovarian cancerW E Lucas, M Markman, S B Howell
Cancer Treatment Reports|October 1, 1982
Modulation of cytarabine metabolism in the human promyelocytic leukemia cell line HL-60 by polyhydroxy-substituted benzohydroxamic acidsS B Howell, S Gill, H L Elford
Cancer Research|March 1, 1981
Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicityS B Howell, S J Mansfield, R Taetle
Cancer Drug Delivery|January 1, 1984
Combination intracavitary chemotherapy for malignant pleural diseaseM Markman, S B Howell, M R Green
Cancer Research|October 1, 1979
Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude miceS B Howell, R S Jenkins, J Streifel
The Journal of Biological Chemistry|March 5, 1990
Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetateS Isonishi, P A Andrews, S B Howell
Clinical Pharmacology and Therapeutics|March 1, 1984
Kinetics of sodium thiosulfate, a cisplatin neutralizerM Shea, J A Koziol, S B Howell
Pageof 26

Showing results (61-70 of 260) with videos related to

Sort By:
Pageof 26
Cancer Treatment Reports|February 1, 1985
Intracavitary cisplatin chemotherapy for mesotheliomaC E Pfeifle, S B Howell, M Markman
Cancer Chemotherapy and Pharmacology|January 1, 1981
Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexateS B Howell, S J Mansfield, R Taetle
Anticancer Research|November 1, 1994
In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenograftsR Jamshidipour, E B Pinho, S B Howell
American Journal of Obstetrics and Gynecology|June 15, 1985
Intraperitoneal chemotherapy for advanced ovarian cancerW E Lucas, M Markman, S B Howell
Cancer Treatment Reports|October 1, 1982
Modulation of cytarabine metabolism in the human promyelocytic leukemia cell line HL-60 by polyhydroxy-substituted benzohydroxamic acidsS B Howell, S Gill, H L Elford
Cancer Research|March 1, 1981
Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicityS B Howell, S J Mansfield, R Taetle
Cancer Drug Delivery|January 1, 1984
Combination intracavitary chemotherapy for malignant pleural diseaseM Markman, S B Howell, M R Green
Cancer Research|October 1, 1979
Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude miceS B Howell, R S Jenkins, J Streifel
The Journal of Biological Chemistry|March 5, 1990
Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetateS Isonishi, P A Andrews, S B Howell
Clinical Pharmacology and Therapeutics|March 1, 1984
Kinetics of sodium thiosulfate, a cisplatin neutralizerM Shea, J A Koziol, S B Howell
Pageof 26